Spironolactone Tablet, Coated
Product Images NDC 68071-3967

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-3967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (6871 39673)

Pdp (6871 39673)
Label for Spironolactone 25 mg coated tablets, oral dosage form, marketed by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets per package, with prescription-only status. It includes the NDC number 68071-3967-3 and cautions to keep out of reach of children and store at controlled temperature (68-77°F).*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve graph comparing Spironolactone and placebo groups over time in months. The y-axis represents probability, and the x-axis represents months. Two curves are shown: one for Spironolactone (n=822) and one for placebo (n=841), with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a clinical study. Subgroups include age, sex, race, LVEF %, heart failure type, NYHA class, diabetes status, serum creatinine, Cr clearance, potassium levels, digoxin usage, ACEI usage, and beta blocker usage. The horizontal axis ranges from 0.2 to 1.4 with labels indicating "Spironolactone better" to the left and "Placebo better" to the right. Sample sizes and subgroup percentages are also listed.*
FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure diagram of spironolactone, showing its molecular framework including steroid rings and attached functional groups as depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.